Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions

Mutations in CCAAT enhancer binding protein A gene (CEBPA) are one of the common genetic alterations in acute myeloid leukemia (AML). Recently, the emergence of new evidence makes it necessary to reconsider the subsets and treatment of AML patients with CEBPA mutations. This review will summarize th...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Long, Shi, Yuan-Yuan, Liu, Zeng-Yan, Gao, Su-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844020/
https://www.ncbi.nlm.nih.gov/pubmed/35178345
http://dx.doi.org/10.3389/fonc.2022.806137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844020/
https://www.ncbi.nlm.nih.gov/pubmed/35178345
http://dx.doi.org/10.3389/fonc.2022.806137

Ejemplares similares